logo

For the Inventor, By the Inventor

Lincolnshire, IL, United States of America

Biosante Pharmaceuticals, Inc.


USPTO Granted Patents = 12

% Expired Patents = 50.0



Trademarks = 2

Forward Citations = 169

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Karin Ute Jooss (8 out of 22 patents)

silverMedal Jianmin Fang (4 out of 8 patents)

bronzeMedal Andrew Simmons (4 out of 7 patents)

4.  Steve J D Bell (2 out of 3 patents)

5.  Jing Jing Qian (2 out of 6 patents)

6.  Jing-Jing Qian (2 out of 4 patents)

7.  Alan J Korman (1 out of 88 patents)

8.  Minh Nguyen (1 out of 9 patents)

9.  Thomas Harding (1 out of 11 patents)

10.  Dale Ando (1 out of 12 patents)

11.  William G Nelson (1 out of 17 patents)

12.  Kathryn E Koprivnikar (1 out of 3 patents)

13.  Betty Li (1 out of 3 patents)

14.  Qing He (1 out of 2 patents)

15.  Jooeun Bae (1 out of 1 patent)


12 patents:

1. 8287856 - PD-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof (2012-10-16),
2. 7939271 - Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer (2011-05-10),
3. 7919079 - Cancer immunotherapy compositions and methods of use (2011-04-05),
4. 7901902 - Methods and compositions for identifying a cellular immune response against prostate cancer (2011-03-08),
5. 7858083 - Pan cancer oncolytic vectors and methods of use thereof (2010-12-28),
6. 7714119 - AAV vector compositions and methods for enhanced expression of immunoglobulins using the same (2010-05-11),
7. 7709224 - Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site (2010-05-04),
8. 7662623 - Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site (2010-02-16),
9. 7645587 - Cancer-associated antigens and methods of their identification and use (2010-01-12),
10. 7632509 - Methods to express recombinant proteins from lentiviral vectors (2009-12-15),
11. 6355271 - Therapeutic calcium phosphate particles and methods of manufacture and use (2002-03-12),
12. 6183803 - Method for processing milk (2001-02-06),
Company Overview
Biosante Pharmaceuticals, Inc. is a biopharmaceutical company based in Lincolnshire, Illinois, focused on developing innovative therapies for various medical conditions. The company specializes in the research and development of treatments in the fields of oncology and metabolic diseases, leveraging advanced drug delivery systems and proprietary technologies. With a commitment to improving patient outcomes, Biosante aims to address unmet medical needs through its cutting-edge therapeutic solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Biosante Pharmaceuticals, Inc. USPTO Patent Assignee Logo
12 Patents

#14 in Lincolnshire, IL

#1,254 in Illinois

#25,540 in US

#48,129 in the World

Lincolnshire, IL (US)
Lincolnshire, IL, United States of America

Biosante Pharmaceuticals, Inc.

Forward Citations = 169

25 inventors:

goldMedal Karin Ute Jooss (8 out of 22 patents)

silverMedal Jianmin Fang (4 out of 8 patents)

bronzeMedal Andrew Simmons (4 out of 7 patents)

4.  Steve J D Bell (2 out of 3 patents)

5.  Jing Jing Qian (2 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biosante Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/biosante-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…